It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(visit the link for the full news article)
NEW YORK, March 16 (UPI) -- Some researchers are questioning the ethics of prescribing higher-than-necessary doses of high-priced drugs in the United States.
..Some researchers say that for many patients as little as one-fourth of the standard dose is effective, and could save more than $200,000 a year per Gaucher patient. About 1,500 people in the United States take the drug, the newspaper said.
"It is economic malpractice to give a much higher dose of an expensive drug than is required," Dr. Ernest Beutler, an authority on Gaucher disease at the Scripps Research Institute, was quoted by the newspaper as saying.